August 24, 2021
A key health ministry advisory committee will discuss a batch of new medicines for regulatory approval at its meeting on September 6, including Astellas Pharma’s antibody-drug conjugate (ADC) Padcev (enfortumab vedotin). The panel’s nod is expected to put them in...read more